Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options
Redmond, William
Display my h-index
Publications in VIVO
 
    Export Publications Table
co-author
Co-author Network
map of science
Map of Science
Biosketch in .docx format  Create Biosketch

Redmond, William

Graduate Student
share the uri qr icon Close

Positions

  • 2016 - Director, Immune Monitoring Laboratory, Earle A. Chiles Research Institute
  • 2013 - Faculty Member Adjunct, Oregon Health & Science University

Websites

  • Doctoral Dissertation
  • Publications
  • Background
  • Contact
  • Identity
  • View All
scroll to property group menus

Publications

recent publications
  • All Publications
  • PubMed Display for Export
  • Publications without PubMed PMIDs

  • academic article

    • Conrad, V. K., Dubay, C. J., Malek, M., Brinkman, R. R., Koguchi, Y., Redmond, W. L. Implementation and validation of an automated flow cytometry analysis pipeline for human immune profiling Cytometry Part A  2019 95A:183-191  DOI:10.1002/cyto.a.23664  PMID:30570217
    • Emerson, D. A., Redmond, W. L. Overcoming tumor-induced immune suppression: from relieving inhibition to providing costimulation with T cell agonists Biodrugs  2018 32:221-231  DOI:10.1007/s40259-018-0277-2  PMID:29637478
    • Wrangle, J. M., Velcheti, V., Patel, M. R., Garrett-Mayer, E., Hill, E. G., Ravenel, J. G., Miller, J. S., Farhad, M., Anderton, K., Lindsey, K., Taffaro-Neskey, M., Sherman, C., et al. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial Lancet Oncology  2018 19:694-704  DOI:10.1016/s1470-2045(18)30148-7  PMID:29628312
    • Farhad, M., Rolig, A. S., Redmond, W. L. The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment Oncoimmunology  2018 7  DOI:10.1080/2162402x.2018.1434467  PMID:29872573  PMCID:PMC5980349
    • Emens, L. A., Ascierto, P. A., Darcy, P. K., Demaria, S., Eggermont, A. M. M., Redmond, W. L., Seliger, B., Marincola, F. M. Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape European Journal of Cancer  2017 81:116-129  DOI:10.1016/j.ejca.2017.01.035  PMID:28623775
    • Graff, J. N., Alumkal, J. J., Drake, C. G., Thomas, G. V., Redmond, W. L., Farhad, M., Cetnar, J. P., Ey, F. S., Bergan, R. C., Slottke, R., Beer, T. M. Early evidence of anti-PD-1 activity in enzalutamide-resistant prostate cancer Oncotarget  2016 7:52810-52817  DOI:10.18632/oncotarget.10547  PMID:27429197  PMCID:PMC5288150
    • McNamara, M. J., Hilgart-Martiszus, I., Echenique, D. M. B., Linch, S. N., Kasiewicz, M. J., Redmond, W. L. Interferon-γ production by peripheral lymphocytes predicts survival of tumor-bearing mice receiving dual PD-1/CTLA-4 blockade Cancer Immunology Research  2016 4:650-657  DOI:10.1158/2326-6066.cir-16-0022  PMID:27262113
    • Linch, S. N., Redmond, W. L. How do I steer this thing? Using dendritic cell targeted vaccination to more effectively guide the antitumor immune response with combination immunotherapy Journal for Immunotherapy of Cancer  2016 4  DOI:10.1186/s40425-016-0135-z  PMID:27330804  PMCID:PMC4915175
    • Linch, S. N., Kasiewicz, M. J., McNamara, M. J., Hilgart-Martiszus, I. F., Farhad, M., Redmond, W. L. Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice Proceedings of the National Academy of Sciences of the United States of America  2016 113:E319-E327  DOI:10.1073/pnas.1510518113  PMID:26729864  PMCID:PMC4725491
    • Redmond, W. L., Linch, S. N. Combinatorial immunotherapeutic approaches to restore the function of anergic tumor-reactive cytotoxic CD8(+) T cells Human Vaccines & Immunotherapeutics  2016 12:2519-2522  DOI:10.1080/21645515.2016.1193277  PMID:27459422  PMCID:PMC5084978
    • Linch, S. N., McNamara, M. J., Redmond, W. L. OX40 agonists and combination immunotherapy: putting the pedal to the metal Frontiers in Oncology  2015 5  DOI:10.3389/fonc.2015.00034  PMID:25763356  PMCID:PMC4329814
    • Redmond, W. L., Linch, S. N., Kasiewicz, M. J. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity Cancer Immunology Research  2014 2:142-153  DOI:10.1158/2326-6066.cir-13-0031-t  PMID:24778278  PMCID:PMC4007342
    • Linch, S. N., Redmond, W. L. Combined OX40 ligation plus CTLA-4 blockade: more than the sum of its parts Oncoimmunology  2014 3  DOI:10.4161/onci.28245  PMID:25050194  PMCID:PMC4091104
    • McNamara, M. J., Kasiewicz, M. J., Linch, S. N., Dubay, C., Redmond, W. L. Common gamma chain (gammac) cytokines differentially potentiate TNFR family signaling in antigen-activated CD8(+) T cells Journal for Immunotherapy of Cancer  2014 2  DOI:10.1186/s40425-014-0028-y  PMID:25411639  PMCID:PMC4236884
    • Crittenden, M. R., Savage, T., Cottam, B., Bahjat, K. S., Redmond, W. L., Bambina, S., Kasiewicz, M., Newell, P., Jackson, A. M., Gough, M. J. The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor PLoS One  2013 8  DOI:10.1371/journal.pone.0069527  PMID:23936036  PMCID:PMC3723876
    • Redmond, W. L., Triplett, T., Floyd, K., Weinberg, A. D. Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression PLoS One  2012 7  DOI:10.1371/journal.pone.0034467  PMID:22496812  PMCID:PMC3319580
    • Gough, M. J., Crittenden, M. R., Sarff, M., Pang, P., Seung, S. K., Vetto, J. T., Hu, H. M., Redmond, W. L., Holland, J., Weinberg, A. D. Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice Journal of Immunotherapy  2010 33:798-809  DOI:10.1097/CJI.0b013e3181ee7095  PMID:20842057  PMCID:PMC3563298
    • Jensen, S. M., Maston, L. D., Gough, M. I., Ruby, C. E., Redmond, W. L., Crittenden, M., Li, Y., Puri, S., Poehlein, C. H., Morris, N., Kovacsovics-Bankowski, M., Moudgil, T., et al. Signaling through OX40 enhances antitumor immunity Seminars in Oncology  2010 37:524-532  DOI:10.1053/j.seminoncol.2010.09.013  PMID:21074068  PMCID:PMC2997672
    • Redmond, W. L., Gough, M. J., Weinberg, A. D. Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo European Journal of Immunology  2009 39:2184-2194  DOI:10.1002/eji.200939348  PMID:19672905  PMCID:PMC3509800
    • Redmond, W. L., Ruby, C. E., Weinbergr, A. D. The role of OX40-mediated co-stimulation in T-cell activation and survival Critical Reviews in Immunology  2009 29:187-201  PMID:19538134  PMCID:PMC3180959
    • Gough, M. J., Ruby, C. E., Redmond, W. L., Dhungel, B., Brown, A., Weinberg, A. D. OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor Cancer Research  2008 68:5206-5215  DOI:10.1158/0008-5472.can-07-6484  PMID:18593921
    • degree-related publication Redmond, W. L., Wei, C. H., Kreuwel, H. T. C., Sherman, L. A. The apoptotic pathway contributing to the deletion of naive CD8 T cells during the induction of peripheral tolerance to a cross-presented self-antigen Journal of Immunology  2008 180:5275-5282  PMID:18390708
    • Redmond, W. L., Gough, M. J., Charbonneau, B., Ratliff, T. L., Weinberg, A. D. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist Journal of Immunology  2007 179:7244-7253  PMID:18025166
    • Ruby, C. E., Redmond, W. L., Haley, D., Weinberg, A. D. Anti-OX40 stimulation in vivo enhances CD8(+) memory T cell survival and significantly increases recall responses European Journal of Immunology  2007 37:157-166  DOI:10.1002/eji.200636428  PMID:17183611
    • Redmond, W. L., Weinberg, A. D. Targeting OX40 and OX40L for the treatment of autoimmunity and cancer Critical Reviews in Immunology  2007 27:415-436  PMID:18197805
    • degree-related publication Martinez, X., Kreuwel, H. T. C., Redmond, W. L., Trenney, R., Hunter, K., Rosen, H., Sarvetnick, N., Wicker, L. S., Sherman, L. A. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles Journal of Immunology  2005 175:1677-1685  PMID:16034108
    • degree-related publication Redmond, W. L., Sherman, L. A. Peripheral tolerance of CD8 T lymphocytes Immunity  2005 22:275-284  DOI:10.1016/j.immuni.2005.01.010  PMID:15780985
    • degree-related publication Redmond, W. L., Marincek, B. C., Sherman, L. A. Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo Journal of Immunology  2005 174:2046-2053  PMID:15699134
    • degree-related publication Yadav, D., Judkowski, V., Flodstrom-Tullberg, M., Sterling, L., Redmond, W. L., Sherman, L., Sarvetnick, N. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets Journal of Immunology  2004 173:3631-3639  PMID:15356107
    • degree-related publication Redmond, W. L., Hernandez, J., Sherman, L. A. Deletion of naive CD8 T cells requires persistent antigen and is not programmed by an initial signal from the tolerogenic APC Journal of Immunology  2003 171:6349-6354  PMID:14662832
    • degree-related publication Hernandez, J., Aung, S., Redmond, W. L., Sherman, L. A. Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen Journal of Experimental Medicine  2001 194:707-717  DOI:10.1084/jem.194.6.707  PMID:11560988  PMCID:PMC2195957
    • McKisic, M. D., Redmond, W. L., Barthold, S. W. T cell-mediated pathology in murine lyme borreliosis Journal of Immunology  2000 164:6096-6099  PMID:10843657
scroll to property group menus

Background

education and training

  • Ph.D. in Biology, Scripps Research 1999 - 2004
  • B.S. in Biology, University of California, Davis 1993 - 1997

advisee of

  • graduate advising relationship

    • Sherman, Linda, Ph.D.  candidacy, 2000 - 2004
scroll to property group menus

Contact

full name

  • William L Redmond

geographic location

  • Scripps California 
scroll to property group menus

Identity

ORCID iD

  • ORCID iD http://orcid.org/0000-0002-2572-1731

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support